Danocrine

Indicated to manage endometriosis, utilized to support hormonal regulation.

Strengths: 50 · 100 · 200mg

Medicine details

Therapeutic class

Androgen

Pharmacological class

Synthetic Androgen

Known off-label uses

fibrocystic breast disease

Precautions and warnings

monitor liver function; monitor for masculinising effects; use contraception

Minor side effects

weight gain; acne; oily skin

Moderate side effects

virilisation; menstrual irregularities; hot flushes

Dosage forms

Capsule, hard

Administration route

Oral use

Patient summary

Indicated to manage endometriosis, utilized to support hormonal regulation.

Prescription status

POM

Manufacturer

Sanofi

Onset Time

4–6 weeks

Duration

6–12 months

Storage instructions

Store below 25°C.

Drug interactions

warfarin; ciclosporin; carbamazepine

Age restrictions

Not recommended for children.

Contraindications

pregnancy; breastfeeding; androgen-dependent tumours; severe hepatic dysfunction; porphyria

Serious side effects

hepatotoxicity — requires immediate medical attention; thromboembolism — requires immediate medical attention

Mechanism of action

Danazol is a synthetic androgen derived from ethisterone that inhibits the secretion of pituitary gonadotropins, thus suppressing ovarian function and decreasing the production of oestrogen.

Pregnancy and breastfeeding

Pregnancy: Contraindicated; must use reliable contraception. Breastfeeding: Contraindicated.

Danocrine

Indicated to manage endometriosis, utilized to support hormonal regulation.

Editorial Notes

  • Active ingredient(s): Danazol
  • Listed indication(s): Endometriosis, Hereditary Angioedema

Usually available as

  • 90 tablets - 50 mg730-50-mg-1003
  • 60 tablets - 100 mg730-100-mg-993
  • 30 tablets - 200 mg730-200-mg-997